Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.

NCT05741593 | Recruiting

• 2 other identifiers: 69HCL22_10742023-A00181-44
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.

Conditions

Stroke

Keywords

Qualitative study; semi-structured interview; antithrombotic; stroke; medication adherence

Outcome Measures

Primary Outcomes (1)

• Analysis of the verbatim from the transcription of the recorded interviews.

  Describing the content of discussions, relating to antithrombotic treatment for secondary prevention, between elderly patients previously treated with antithrombotics and admitted to hospital for an ischemic stroke and a pharmacist

  one year

Secondary Outcomes (4)

• Analysis of verbatim statements from the transcription of recorded interviews on patients' representations and beliefs regarding antithrombotics

  15 to 60 minutes per patient

• Analysis of verbatim statements from the transcription of recorded interviews on patients' medication adherence to antithrombotics

  15 to 60 minutes per patient

• Analysis of verbatim statements from the transcription of recorded interviews on the impact of the occurrence of stroke or recurrence of stroke on medication adherence

  15 to 60 minutes per patient

• Analysis of verbatim statements from the transcription of recorded interviews on the obstacles and levers to medication adherence

  15 to 60 minutes per patient

Study Arms (1)

Patients having had a stroke

elderly patients previously treated with an antithrombotic and admitted to hospital for an ischemic stroke

Other: Analysis of the verbatim from the transcription of the recorded interviews.

Interventions

Analysis of the verbatim from the transcription of the recorded interviews. OTHER

recorded semi-structured interviews between the patients and the pharmacist

Patients having had a stroke

Eligibility Criteria

• Age: 65 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged 65 and over, hospitalized for an ischemic stroke or a recurrence of ischemic stroke, being already treated with an antithrombotic treatment hospitalized at the Charpennes hospital with a plan to return home

You may qualify if:

• Patients aged 65 and over
• Patients hospitalized for an ischemic stroke or a recurrence of ischemic stroke, already being treated with an antithrombotic treatment (antiplatelet agent or anticoagulant ) prior to the stroke
• Patients living at home and with a plan to return home.
• Patients who did not object to the study and who gave their consent for the recording of the interview

You may not qualify if:

• Patients with cognitive disorders or stroke sequelae that do not allow a semi-directive interview to be carried out (at medical discretion).
• Non-French speaking patients

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

institute of aging - Hôpital des Charpennes

Villeurbanne, 69100, France

RECRUITING

MeSH Terms

Conditions

Stroke; Medication Adherence

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Patient Compliance; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Central Study Contacts

Teddy Novais, PharmD, PhD

CONTACT

+33472432155; teddy.novais@chu-lyon.fr

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 14, 2023
• First Posted: February 23, 2023
• Study Start: April 1, 2025
• Primary Completion: April 1, 2026
• Study Completion: April 1, 2026
• Last Updated: November 18, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)